End-of-day quote
Shenzhen S.E.
06:00:00 2024-07-02 pm EDT
|
5-day change
|
1st Jan Change
|
9.69
CNY
|
-1.22%
|
|
-6.92%
|
-39.51%
|
Fiscal Period: December |
2021
|
2022
|
2023
|
---|
Capitalization
1 |
13,324
|
5,634
|
6,248
|
Enterprise Value (EV)
1 |
8,932
|
2,048
|
3,817
|
P/E ratio
|
5.21
x
|
85.4
x
|
-47.1
x
|
Yield
|
5.63%
|
3.73%
|
3.12%
|
Capitalization / Revenue
|
2.71
x
|
3.58
x
|
2.97
x
|
EV / Revenue
|
1.82
x
|
1.3
x
|
1.81
x
|
EV / EBITDA
|
3.22
x
|
-604
x
|
153
x
|
EV / FCF
|
20.8
x
|
-16.4
x
|
-14.4
x
|
FCF Yield
|
4.8%
|
-6.11%
|
-6.93%
|
Price to Book
|
2.03
x
|
0.92
x
|
1.08
x
|
Nbr of stocks (in thousands)
|
390,008
|
390,008
|
390,008
|
Reference price
2 |
34.16
|
14.45
|
16.02
|
Announcement Date
|
4/27/22
|
4/24/23
|
4/24/24
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net sales
1 |
967.5
|
1,171
|
4,778
|
4,909
|
1,573
|
2,105
|
EBITDA
1 |
113.2
|
166.2
|
3,326
|
2,772
|
-3.391
|
24.89
|
EBIT
1 |
77.02
|
119.1
|
3,267
|
2,693
|
-147.2
|
-174.2
|
Operating Margin
|
7.96%
|
10.17%
|
68.36%
|
54.86%
|
-9.36%
|
-8.27%
|
Earnings before Tax (EBT)
1 |
70.33
|
105.8
|
3,192
|
2,784
|
51.27
|
-137.7
|
Net income
1 |
56.67
|
89.27
|
2,664
|
2,342
|
66.92
|
-130.9
|
Net margin
|
5.86%
|
7.62%
|
55.74%
|
47.7%
|
4.26%
|
-6.22%
|
EPS
2 |
0.1923
|
0.3034
|
9.107
|
6.551
|
0.1692
|
-0.3400
|
Free Cash Flow
1 |
-147.5
|
-53.13
|
1,655
|
429
|
-125.1
|
-264.6
|
FCF margin
|
-15.24%
|
-4.54%
|
34.63%
|
8.74%
|
-7.95%
|
-12.57%
|
FCF Conversion (EBITDA)
|
-
|
-
|
49.76%
|
15.48%
|
-
|
-
|
FCF Conversion (Net income)
|
-
|
-
|
62.13%
|
18.32%
|
-
|
-
|
Dividend per Share
|
-
|
0.2564
|
1.709
|
1.923
|
0.5385
|
0.5000
|
Announcement Date
|
3/30/21
|
3/30/21
|
4/25/21
|
4/27/22
|
4/24/23
|
4/24/24
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net Debt
1 |
269
|
258
|
-
|
-
|
-
|
-
|
Net Cash position
1 |
-
|
-
|
1,450
|
4,392
|
3,586
|
2,431
|
Leverage (Debt/EBITDA)
|
2.374
x
|
1.552
x
|
-
|
-
|
-
|
-
|
Free Cash Flow
1 |
-147
|
-53.1
|
1,655
|
429
|
-125
|
-265
|
ROE (net income / shareholders' equity)
|
16%
|
21.7%
|
176%
|
51.4%
|
1.06%
|
-2.12%
|
ROA (Net income/ Total Assets)
|
5.76%
|
7.26%
|
86%
|
31.1%
|
-1.32%
|
-1.57%
|
Assets
1 |
984.6
|
1,230
|
3,098
|
7,530
|
-5,081
|
8,339
|
Book Value Per Share
2 |
1.280
|
1.600
|
8.740
|
16.80
|
15.70
|
14.80
|
Cash Flow per Share
2 |
0.1100
|
0.2400
|
4.020
|
2.170
|
1.240
|
1.990
|
Capex
1 |
203
|
150
|
429
|
979
|
208
|
103
|
Capex / Sales
|
20.99%
|
12.85%
|
8.99%
|
19.93%
|
13.2%
|
4.9%
|
Announcement Date
|
3/30/21
|
3/30/21
|
4/25/21
|
4/27/22
|
4/24/23
|
4/24/24
|
|
1st Jan change
|
Capi.
|
---|
| -39.51% | 525M | | +7.77% | 27.07B | | +16.87% | 2.48B | | +21.85% | 2.4B | | -49.93% | 2.13B | | -31.11% | 2.06B | | +25.56% | 1.9B | | -19.71% | 1.71B | | +8.48% | 1.33B | | +28.11% | 1.3B |
Medical Supplies
|